NCT00559377 - FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2012

Study Completion Date

May 31, 2014

Conditions

Cervical AdenocarcinomaCervical Squamous Cell CarcinomaStage IB Cervical CancerStage IIA Cervical CancerStage IIB Cervical CancerStage III Cervical CancerStage IVA Cervical CancerStage IVB Cervical Cancer

Interventions

OTHER

18F-fluoromisonidazole

Undergo \^18F FMISO PET scan

RADIATION

fluorodeoxyglucose F 18

Undergo \^18F FDG PET scan

PROCEDURE

positron emission tomography

Undergo \^18F-FMISO and \^18F FDG PET scan

OTHER

tissue oxygen measurement

Undergo \^18 F FMISO PET and \^18F FDG PET

Trial Locations (1)

98195

University of Washington Medical Center, Seattle

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH